Tsai HL, Lin CC, Sung YC, Chen SH, et al. The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study. Br J Cancer 2023;129:947-955.
PMID: 37488448